[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: Experience in 100 consecutive patients

Marino Cimitan, Roberto Bortolus, Sandro Morassut, Vincenzo Canzonieri, Antonio Garbeglio, Tanja Baresic, Eugenio Borsatti, Annalisa Drigo, Mauro G. Trovò

Research output: Contribution to journalArticle

Abstract

Purpose: We evaluated the potential of PET/CT and [18F] fluoromethylcholine (FCH) in the assessment of suspected recurrence of prostate cancer after treatment. Methods: One hundred consecutive prostate cancer patients with a persistent increase in serum PSA (>0.1 ng/ml) after radical prostatectomy (58 cases), radiotherapy (21 cases) or hormonal therapy alone (21 cases) were investigated. After injection of 3.7-4.07 MBq/kg of FCH, both early (at 60 min) PET/CT scans were performed in 43 patients, delayed PET/CT scans in 53 patients and early PET/CT scans in four patients. Results: Of the 100 patients, 54 (PSA 0.22-511.79 ng/ml) showed positive FCH PET/CT scans. Thirty-seven patients had bone and/or abdominal lymph node uptake, while 17 showed pelvic activity. Malignant disease was confirmed in all but one. Delayed SUVmax of bone metastases was significantly higher (p

Original languageEnglish
Pages (from-to)1387-1398
Number of pages12
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume33
Issue number12
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Prostatic Neoplasms
Recurrence
Bone and Bones
Prostatectomy
fluorocholine
Radiotherapy
Lymph Nodes
Neoplasm Metastasis
Injections
Positron Emission Tomography Computed Tomography
Therapeutics
Serum
fluoromethylcholine

Keywords

  • Choline
  • PET
  • Prostate cancer

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse : Experience in 100 consecutive patients. / Cimitan, Marino; Bortolus, Roberto; Morassut, Sandro; Canzonieri, Vincenzo; Garbeglio, Antonio; Baresic, Tanja; Borsatti, Eugenio; Drigo, Annalisa; Trovò, Mauro G.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, No. 12, 12.2006, p. 1387-1398.

Research output: Contribution to journalArticle

@article{bb3323a307bf4ccdb27c1270f18be1f0,
title = "[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: Experience in 100 consecutive patients",
abstract = "Purpose: We evaluated the potential of PET/CT and [18F] fluoromethylcholine (FCH) in the assessment of suspected recurrence of prostate cancer after treatment. Methods: One hundred consecutive prostate cancer patients with a persistent increase in serum PSA (>0.1 ng/ml) after radical prostatectomy (58 cases), radiotherapy (21 cases) or hormonal therapy alone (21 cases) were investigated. After injection of 3.7-4.07 MBq/kg of FCH, both early (at 60 min) PET/CT scans were performed in 43 patients, delayed PET/CT scans in 53 patients and early PET/CT scans in four patients. Results: Of the 100 patients, 54 (PSA 0.22-511.79 ng/ml) showed positive FCH PET/CT scans. Thirty-seven patients had bone and/or abdominal lymph node uptake, while 17 showed pelvic activity. Malignant disease was confirmed in all but one. Delayed SUVmax of bone metastases was significantly higher (p",
keywords = "Choline, PET, Prostate cancer",
author = "Marino Cimitan and Roberto Bortolus and Sandro Morassut and Vincenzo Canzonieri and Antonio Garbeglio and Tanja Baresic and Eugenio Borsatti and Annalisa Drigo and Trov{\`o}, {Mauro G.}",
year = "2006",
month = "12",
doi = "10.1007/s00259-006-0150-2",
language = "English",
volume = "33",
pages = "1387--1398",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Berlin Heidelberg",
number = "12",

}

TY - JOUR

T1 - [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse

T2 - Experience in 100 consecutive patients

AU - Cimitan, Marino

AU - Bortolus, Roberto

AU - Morassut, Sandro

AU - Canzonieri, Vincenzo

AU - Garbeglio, Antonio

AU - Baresic, Tanja

AU - Borsatti, Eugenio

AU - Drigo, Annalisa

AU - Trovò, Mauro G.

PY - 2006/12

Y1 - 2006/12

N2 - Purpose: We evaluated the potential of PET/CT and [18F] fluoromethylcholine (FCH) in the assessment of suspected recurrence of prostate cancer after treatment. Methods: One hundred consecutive prostate cancer patients with a persistent increase in serum PSA (>0.1 ng/ml) after radical prostatectomy (58 cases), radiotherapy (21 cases) or hormonal therapy alone (21 cases) were investigated. After injection of 3.7-4.07 MBq/kg of FCH, both early (at 60 min) PET/CT scans were performed in 43 patients, delayed PET/CT scans in 53 patients and early PET/CT scans in four patients. Results: Of the 100 patients, 54 (PSA 0.22-511.79 ng/ml) showed positive FCH PET/CT scans. Thirty-seven patients had bone and/or abdominal lymph node uptake, while 17 showed pelvic activity. Malignant disease was confirmed in all but one. Delayed SUVmax of bone metastases was significantly higher (p

AB - Purpose: We evaluated the potential of PET/CT and [18F] fluoromethylcholine (FCH) in the assessment of suspected recurrence of prostate cancer after treatment. Methods: One hundred consecutive prostate cancer patients with a persistent increase in serum PSA (>0.1 ng/ml) after radical prostatectomy (58 cases), radiotherapy (21 cases) or hormonal therapy alone (21 cases) were investigated. After injection of 3.7-4.07 MBq/kg of FCH, both early (at 60 min) PET/CT scans were performed in 43 patients, delayed PET/CT scans in 53 patients and early PET/CT scans in four patients. Results: Of the 100 patients, 54 (PSA 0.22-511.79 ng/ml) showed positive FCH PET/CT scans. Thirty-seven patients had bone and/or abdominal lymph node uptake, while 17 showed pelvic activity. Malignant disease was confirmed in all but one. Delayed SUVmax of bone metastases was significantly higher (p

KW - Choline

KW - PET

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=33845357517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845357517&partnerID=8YFLogxK

U2 - 10.1007/s00259-006-0150-2

DO - 10.1007/s00259-006-0150-2

M3 - Article

C2 - 16865395

AN - SCOPUS:33845357517

VL - 33

SP - 1387

EP - 1398

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 12

ER -